Discover the latest biotech funding in 2026 on our dedicated page. We meticulously curate and categorize significant fundraising events to keep you informed about the trends and investments driving the industry forward. 

Looking for new funding opportunities and partnerships? Join Inpart’s global network of decision-makers and research teams seeking the latest assets, research, and expertise.

Biotech funding tracker: key moves in 2026

Tool: funding tracker

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Get our biotech funding tracker in a Google Sheet—exclusive to Labiotech newsletter subscribers.

By clicking this I agree to receive Labiotech’s newsletter and understand that my personal data will be processed according to the Privacy Policy.*
Labiotech.eu

Navigating biotech funding in 2026: additional resources

In addition to our biotech funding tracker, we offer additional resources to help you navigate the investment landscape. You can also explore past trackers to gain insights into how the funding landscape has evolved.

Check out these helpful resources:

Where does the biotech funding data on the Labiotech tracker come from?

At Labiotech, we focus on identifying biotech funding that truly matters. We combine two key approaches:

    1. News & press releases monitoring: We closely monitor the latest news and press releases, ensuring we only feature investments that could have a real impact on the industry.

    1. Specialized databases: We leverage trusted platforms such as TechCrunch to identify the funding with the most promise.

Our editorial team then organizes this information based on factors like therapeutic approach, technology, funding type (e.g., Series A, B), and more.